Type 2 diabetes
Janssen-Cilag Ltd are the UK marketing authorisation holder.
Invokana® tablets (canagliflozin hemihydrate)
Patient Information LeafletVokanamet® (canagliflozin/metformin)
This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See www.mhra.gov.uk/yellowcard for how to report side effects.
Patient Information Leaflet